Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPOXX Drug-Drug Interaction Study with Phosphate Binders
NCT04485039Phase 4Completed
- Sponsor
- SIGA Technologies
- Start
- Jun 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tecovirimat in smallpox, sponsored by SIGA Technologies. Started Jun 2022; status: completed.
02
Drugs
tecovirimat
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT04485039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485039.